Stockreport

Adamis: Sandoz Is Ready To Challenge EpiPen Dominance [Seeking Alpha]

Novartis AG  (NVS) 
Last novartis ag earnings: 4/28 01:00 am Check Earnings Report
US:NYSE Investor Relations: novartis.com/investors
PDF Adamis: Sandoz Is Ready To Challenge EpiPen DominanceSummaryOn Dec. 6, Adamis and Sandoz announced that Symjepi, an epinephrine injector, would be launching in the marke [Read more]